Ani Pharmaceuticals Inc (ANIP)

EBITDA Growth

53.84%

Quarterly · Period ending:

ANIP logo

ANIP EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported53.84%
ANIP Quarterly EBITDA YoY % (-365.21% → 53.84%)
High-resolution chart · PNG

ANIP ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Ani Pharmaceuticals Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
53.8401%
18.6283%
417.956%
555.7642%
129.9543%
8.3839%
-32.1378%
-140.5212%
-36.8838%
81.6742%
26.1499%
218.6682%
1,235.2593%
619.5896%
236.3029%
54.8041%
147.1369%
-135.2026%
-214.9761%
-51.8125%
-1,809.3333%
300.7162%
131.514%
-17.0823%
-101.1962%
-83.5534%
-75.6666%
-10.0685%
20.9958%
38.8794%
36.4912%
13.053%
10.4433%
29.6827%
103.7357%
19.1764%
13.0602%
10.1022%
-15.6582%
32.0823%
26.666%
-5.682%
-30.4878%
11.8474%
660.3763%
159.5045%
209.3012%
687.4161%
-4.6356%
303.8268%
15,258.9186%
119.3797%
76.842%
79.627%
100.3035%
50.8962%
44.4235%
40.6611%
36.3211%
-11.8477%
-27.7179%
-91.1234%
43.7247%
-130.1147%
-122.3018%
-121.0257%
-1,161.4008%
27.1339%
16.6146%
-1.8993%
7.6422%
-213.6946%
-111.4139%
-113.2882%
-120.1076%
-154.4352%
-14.7379%
43.7213%
663.2654%
56.6895%
14.6575%
-15.9564%
57.7338%
34.012%
-2.0526%
-16.0982%
-142.7356%
-106.7988%
-62.3409%
-100.5693%
-344.3536%
-82.0354%
-8.4267%
-13.0402%
72.6429%
-3,724.774%
-79.2394%
-56.7768%
-53.6552%
103.2722%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.